GlassScriptPhysician profile
Betsy Thomson
NPI 1104597103
$2,976.10
in general payments reported to CMS, 2019-2025
24 companies · $945 in 2025
The $945 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $184 · 2022: $505 · 2023: $415 · 2024: $926 · 2025: $945.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,286.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $490.28 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $409.89 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $368.04 | 2021-2025 | Freestyle Libre 3 |
| Amgen INC. | $367.02 | 2022-2025 | Evenity, Prolia, Tepezza |
| Insulet Corporation | $310.96 | 2022-2025 | Omnipod |
| Amneal Pharmaceuticals LLC | $222.20 | 2022-2025 | Unithroid |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.00 | 2022-2025 | Jardiance, Tradjenta |
| Horizon Therapeutics Plc | $68.26 | 2023 | Tepezza |
| Tandem Diabetes Care, INC. | $67.18 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| 3b Medical, INC. | $62.16 | 2025 | Luna |
| Bayer Healthcare Pharmaceuticals INC. | $57.93 | 2022-2025 | |
| Medtronic, INC. | $49.77 | 2021-2024 | Minimed 780g |
| Xeris Pharmaceuticals, INC. | $39.39 | 2022-2024 | Gvoke Hypopen |
| Alexion Pharmaceuticals, INC. | $35.35 | 2023-2024 | Strensiq |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beta Bionics, INC. | $28.15 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Soleno Therapeutics, INC. | $26.75 | 2025 | Vykat Xr |
| Sequel Med Tech, LLC | $24.87 | 2025 | Twiist |
| Rhythm Pharmaceuticals, INC. | $23.85 | 2024 | Imcivree |
| Verona Pharma, INC. | $23.22 | 2025 | Ohtuvayre |
| Cequr Corporation | $21.65 | 2024 | Cequr Simplicity |
| Regeneron Healthcare Solutions, INC. | $21.15 | 2025 | Dupixent |
| Abbvie INC. | $20.68 | 2022 | |
| Dexcom, INC. | $15.35 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Betsy Thomson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.